Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. - Wikidata - wikimedia - TriplyDB

Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.

Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.

http://www.wikidata.org/entity/Q34767549

about

Enhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomics Advances in translational bioinformatics: computational approaches for the hunting of disease genes Predictive and prognostic molecular markers for cancer medicine Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans Correcting for intra-experiment variation in Illumina BeadChip data is necessary to generate robust gene-expression profiles Comparative study of joint analysis of microarray gene expression data in survival prediction and risk assessment of breast cancer patients.Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets - improving meta-analysis and prediction of prognosis.Knowledge driven decomposition of tumor expression profiles Can survival prediction be improved by merging gene expression data sets?Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality.Interpreting metabolomic profiles using unbiased pathway models.Analysis of multiple sarcoma expression datasets: implications for classification, oncogenic pathway activation and chemotherapy resistance Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer.Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform.Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer.Molecular genetics complexity impeding research progress in breast and ovarian cancers.Integrating Epigenomics into Pharmacogenomic Studies Single sample expression-anchored mechanisms predict survival in head and neck cancer.Comparison of data-merging methods with SVM attribute selection and classification in breast cancer gene expression Gene interaction enrichment and network analysis to identify dysregulated pathways and their interactions in complex diseases Biclustering reveals breast cancer tumour subgroups with common clinical features and improves prediction of disease recurrence Global transcriptomic profiling using small volumes of whole blood: a cost-effective method for translational genomic biomarker identification in small animals.A hybrid approach of gene sets and single genes for the prediction of survival risks with gene expression data.Differential expression of ERCC-1 in the primary tumors and metastatic lymph nodes of patients with non-small cell lung cancer adenocarcinoma.Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management Prevalence of scientific misconduct among a group of researchers in Nigeria.Sense-antisense gene-pairs in breast cancer and associated pathological pathways.Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-κB survival signatures following GNRH receptor activation.A radiation-derived gene expression signature predicts clinical outcome for breast cancer patients Prediction of breast cancer metastasis by genomic profiling: where do we stand?Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential.Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers.Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.Genomic predictors of outcome and treatment response in breast cancer.Clinical implications of chemotherapy-induced tumor gene expression in human breast cancers.Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab.Triple-negative breast cancer: present challenges and new perspectives.Hyaluronan metabolism in remodeling extracellular matrix: probes for imaging and therapy of breast cancer.

P2860

Q24618080-480F755F-B82F-471C-95A8-7A10D0F49080 Q24642050-2375E0C3-A2B1-4C8D-B1D8-4801E61AE429 Q28743108-A0458853-5837-46B6-B2B2-57A6940670C9 Q30379566-5D5760DB-08E7-41D9-8464-0B99CA73302F Q30493843-87436018-22B3-47E6-9824-98067D9B83A0 Q31011613-1C9C534D-FAE9-465C-8130-3CA141F1F6AA Q33361596-E436B201-FA6D-4B96-8F27-AA13AAA3F950 Q33370712-3D626EE7-3DF6-4322-A80E-364CFA31C9EA Q33407774-FA4D9A50-9E72-42E3-9BF2-5E790A2408BE Q33511962-82B337E9-C7B9-4A43-9BAC-61F8342E4116 Q33531856-DC91A3FC-A101-406A-9D04-45FA42D6E571 Q33535872-D64088C3-C77A-4B68-8E40-F1A60915EF31 Q33549674-5478782F-8A9C-40EE-BB60-C6938FA457A9 Q33584322-2D528ECC-85E4-4CE8-8F2B-8C37F5A1E526 Q33612477-D0A89F77-73BF-43CE-85A2-9C6624FD460D Q33776184-60CCE583-F1CB-42CE-B5B1-618985785AB1 Q33813431-92BF18DB-BD30-4E94-9DC0-92694225D8BA Q33858073-C5F0978D-B8B9-4CA2-BD8C-65A1BA60ED72 Q33980155-F2B7FCCC-1E43-4103-AB7D-C7881F8FEB7D Q34145659-9427D689-4839-414C-A8F6-1E60C97EDEB4 Q34272649-7B96768C-A5AC-4F83-9B1E-8B520B34345F Q34302997-3BE5ADF8-C968-41A2-AD1C-3F931E1585EE Q34584855-3B13C833-D2D2-4ACC-9701-C46DDC4E9454 Q35079266-3B980D98-F16F-4496-99CB-F9E806891B70 Q35620335-EC4BFAEB-5A2B-4980-B7D4-949E24AD127F Q36408318-EB534F52-70E3-42E3-835B-228B2708DC5F Q36441485-61820EB2-A474-41EE-A79D-CC1FD90C4080 Q36489860-7D6412A3-32DC-462F-8AC9-6F48CC955996 Q36561721-DF46543D-FAC5-47F1-976A-F23660D3F6A2 Q36613911-839D8DE0-59E8-416A-BB4A-02672DC52207 Q37143757-A067A720-BA0F-4311-8C16-0B0DBA9D2881 Q37279681-5B27BD15-038C-4B23-A1CC-028E79BE594B Q37364112-5784694F-F2B2-4833-BF5E-7A228188929C Q37383140-D73E7F58-2E31-479D-852E-B9895F6CEC23 Q37453940-99B4CF04-7582-43F5-BC20-B51084CE477E Q37523889-8AD1E4FE-C4D7-464E-824E-F218C82E9CF3 Q37693959-6C773132-A17F-459B-B74C-366ADC6D059A Q37725978-10B5C843-AFC2-495A-A5F3-C5C3317B689C Q37764168-2450B752-63A0-46D5-BF7C-068FF00A7FBA Q37832163-3EB7A114-B5F1-4133-80C2-8B4A673A2DB0

P2860

Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.

http://www.wikidata.org/entity/Q34767549

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Gene expression signatures, cl ...... ized therapy in breast cancer.

@ast

Gene expression signatures, cl ...... ized therapy in breast cancer.

@en

Gene expression signatures, cl ...... ized therapy in breast cancer.

@nl

type

label

Gene expression signatures, cl ...... ized therapy in breast cancer.

@ast

Gene expression signatures, cl ...... ized therapy in breast cancer.

@en

Gene expression signatures, cl ...... ized therapy in breast cancer.

@nl

prefLabel

Gene expression signatures, cl ...... ized therapy in breast cancer.

@ast

Gene expression signatures, cl ...... ized therapy in breast cancer.

@en

Gene expression signatures, cl ...... ized therapy in breast cancer.

@nl

P1433

Q34767549-28D2BFEA-5BF4-4EEE-8B84-533EE03B823B

P1476

Q34767549-2E7B2A2D-E396-48C5-8910-54762C5AD54D

P2093

Q34767549-0A082547-E313-4CFA-862B-24235A86AE08

Q34767549-123D1626-CB25-41AE-A1EF-11F0683129FB

Q34767549-1251B372-FB41-47D0-A130-D8F552511BA7

Q34767549-19A9A7FA-9384-4AC2-9DFD-53C312A24555

Q34767549-1C7EBF36-762A-4C0D-9E73-E04CF91DEDA0

Q34767549-37132D63-867C-409C-ABEC-EE5441A7BEF2

Q34767549-3E35BE29-3748-4729-B569-C2B17978F253

Q34767549-51868FFF-3889-419A-A6B8-E326916C70D8

Q34767549-55418399-ECDB-4D0A-9A9F-8F5E61466123

Q34767549-56E86F15-8441-4027-9C06-80532056AA01

P304

Q34767549-8D3FC6CC-8534-42AB-98E7-520C851BAC3E

P31

Q34767549-AD193DC1-3E33-408A-B5DC-2E2F8D99DAE1

P356

Q34767549-8B2A876E-3B59-4983-9562-A7149CC04D31

P407

Q34767549-927B52B1-F24F-454A-BE0B-A718C46AF4E3

P433

Q34767549-0C80D6A5-F344-48EE-B0DB-B846A8D1B55E

P478

Q34767549-FF67C57D-C8ED-4CC2-84A8-3BCE4E72D994

P50

Q34767549-59B590AF-378E-428D-AFC3-EFB298421C5A

P577

Q34767549-CDF7C17E-DABC-4280-AA03-F2CFE321C9D5

P5875

Q34767549-404077D9-0968-428B-BE1A-40C621F82DED

P698

Q34767549-05DF8B3A-6BAA-4597-B260-87B7222A25B6

P356

JAMA.299.13.1574

P1433

Journal of the American Medical Association

P1476

Gene expression signatures, cl ...... ized therapy in breast cancer.

@en

P2093

Anil Potti

http://www.w3.org/2001/XMLSchema#string

Ariel Anguiano

http://www.w3.org/2001/XMLSchema#string

Carey K Anders

http://www.w3.org/2001/XMLSchema#string

Chaitanya R Acharya

http://www.w3.org/2001/XMLSchema#string

Cynthia A Moylan

http://www.w3.org/2001/XMLSchema#string

David S Hsu

http://www.w3.org/2001/XMLSchema#string

Gary H Lyman

http://www.w3.org/2001/XMLSchema#string

Geoffrey S Ginsburg

http://www.w3.org/2001/XMLSchema#string

Holly K Dressman

http://www.w3.org/2001/XMLSchema#string

Joseph R Nevins

http://www.w3.org/2001/XMLSchema#string

P304

1574-1587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.299.13.1574

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

299

http://www.w3.org/2001/XMLSchema#string

P50

Sascha A Tuchman

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5464482

http://www.w3.org/2001/XMLSchema#string

P698

18387932

http://www.w3.org/2001/XMLSchema#string